Dr Matthew Alexander Lunning, DO | |
988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 | |
(402) 559-4015 | |
(402) 559-8715 |
Full Name | Dr Matthew Alexander Lunning |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 20 Years |
Location | 988102 Nebraska Medical Ctr, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003935081 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | TEP (Nebraska) | Secondary |
207RX0202X | Internal Medicine - Medical Oncology | 563 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Nebraska Medical Center | Omaha, NE | Hospital |
Bellevue Medical Center | Bellevue, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unmc Physicians | 6002728391 | 1320 |
News Archive
In a new report, dozens of scientists, health practitioners and children's health advocates are calling for renewed attention to the growing evidence that many common and widely available chemicals endanger neurodevelopment in fetuses and children of all ages.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
In one of the largest studies of its kind ever conducted, an international team of scientists has thrown new light on the genetic basis of the inflammatory bowel diseases (IBD).
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
› Verified 9 days ago
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
In a new report, dozens of scientists, health practitioners and children's health advocates are calling for renewed attention to the growing evidence that many common and widely available chemicals endanger neurodevelopment in fetuses and children of all ages.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
In one of the largest studies of its kind ever conducted, an international team of scientists has thrown new light on the genetic basis of the inflammatory bowel diseases (IBD).
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Alexander Lunning, DO 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4015 | Dr Matthew Alexander Lunning, DO 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4015 |
News Archive
In a new report, dozens of scientists, health practitioners and children's health advocates are calling for renewed attention to the growing evidence that many common and widely available chemicals endanger neurodevelopment in fetuses and children of all ages.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
In one of the largest studies of its kind ever conducted, an international team of scientists has thrown new light on the genetic basis of the inflammatory bowel diseases (IBD).
VIVUS, Inc. today announced positive results from TA-314, a phase 3 pivotal open-label safety study of avanafil, an investigational drug for the treatment of erectile dysfunction (ED). The study met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements in the International Index of Erectile Function (IIEF).
› Verified 9 days ago
Dr. Marium Ilahi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |